Metabolic signatures and predictive biomarkers of liposomal doxorubicin-induced hypersensitivity in breast cancer: A pilot study
Background: Liposomal doxorubicin hypersensitivity significantly affects breast cancer patients, with widely varying incidence rates (9 % to 46 %). Despite its efficacy, this condition poses a critical barrier to treatment due to the need for precise patient management and the absence of effective p...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2026-01-01
|
| Col·lecció: | Cancer Treatment and Research Communications |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2468294226000158 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|